Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
about
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.
P2860
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@en
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@nl
type
label
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@en
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@nl
prefLabel
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@en
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Biallelic loss of CDKN2A is as ...... acute lymphoblastic leukemia.
@en
P2093
Agata Pastorczak
Bartlomiej Tomasik
Beata Zalewska-Szewczyk
Bernarda Kazanowska
Filip Pierlejewski
Iwona Wlodarska
Jan Styczynski
Joanna Taha
Joanna Trelinska
Marta Bielska
P2860
P304
P356
10.1080/10428194.2016.1228925
P50
P577
2016-10-18T00:00:00Z